Login / Signup

Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.

Karan SinghArushi Gahlot SainiNiranjan KhandelwalPratibha Singhi
Published in: Journal of child neurology (2022)
Our study demonstrates the safety and efficacy of albendazole and praziquantel in combination for complete radiologic resolution in children with persistent neurocysticercosis when compared with albendazole monotherapy or placebo. The combination therapy did not result in increased seizure recurrence or adverse drug reaction compared with albendazole monotherapy.
Keyphrases
  • combination therapy
  • adverse drug
  • young adults
  • emergency department
  • randomized controlled trial
  • clinical trial